• Wall Street opens little changed, tech drags

    5 monthes ago - By Reuters

    Wall Street indexes opened little changed on Friday as losses in Symantec and Nvidia offset gains in healthcare and telecom sectors.
    Read more ...

     

  • Futures tick higher; auto, health stocks in focus

    5 monthes ago - By Reuters

    Wall Street was set to open slightly higher on Friday, with auto and healthcare stocks to be in focus as President Donald Trump is set to address issues related to the two sectors.
    Read more ...

     

  • European stocks take a breather after strong rally

    5 monthes ago - By Chron

    LONDON - European stock markets eased slightly Friday after a strong rally saw many indexes strike multi-week highs. Wall Street was poised for further solid gains at the open despite ongoing geopolitical unease related to President Donald Trump's decision to pull the United States out of the Iran nuclear deal.
    KEEPING SCORE: In Europe, France's CAC 40 was down 0.3 percent at 5,520 while Germany's DAX also fell 0.3 percent to 12,986. The FTSE 100 index of leading British shares was 0.1 percent lower at 7,696. U.S. stocks are expected to open higher with Dow futures and the broader S&P 500...
    Read more ...

     

  • Futures higher; healthcare, tech stocks in focus

    5 monthes ago - By Reuters

    U.S. stock index futures edged higher on Friday, setting up Wall Street to build on a week-long rally, but focus will be on technology and healthcare stocks after tepid results from Nvidia and President Donald Trump's renewed focus on drug pricing.
    Read more ...

     

  • Wall Street's whispering that Trump may take a hammer to one of healthcare's most lucrative businesses

    5 monthes ago - By Chron

    Reuters/Carlos Barria
    Wall Street analysts have been reading the tea leaves before President Donald Trump's healthcare speech Friday, and some think pharmacy benefit managers could be in trouble.
    PBMs manage the lists of what drugs your healthcare provider will and will not pay for. They're supposed to keep costs down.
    But Trump officials have been saying that one of the main ways PBMs claim to do this, by taking rebates from drug manufacturers, actually creates incentives that drives prices up.
    Wall Street thinks President Donald Trump could announce measures that will take a jackhammer...
    Read more ...

     

  • Wall Street's whispering that Trump may take a hammer to one of healthcare's most lucrative businesses

    Wall Street's whispering that Trump may take a hammer to one of healthcare's most lucrative businesses

    5 monthes ago - By Business Insider

    Wall Street analysts have been reading the tea leaves before President Trump's healthcare speech Friday, and some think pharmacy benefit managers could be in trouble.
    PBMs manage the lists of what drugs your healthcare provider will and will not pay for. They're supposed to keep costs down.
    But Trump officials have been saying that one of the main ways PBMs claim to do this, by taking rebates from drug manufacturers, actually creates incentives the drives prices up.
    Wall Street thinks President Donald Trump could announce measures that will take a jackhammer to an incredibly profitable...
    Read more ...